 Pfizer Inc.'s nearly $100 billion offer to buy British rival AstraZeneca PLC, if accepted, would allow the pharmaceutical giant to move its official headquarters overseas, saving the company that started 165 years ago on a Brooklyn, N.Y., street corner billions in taxes over the next decade.. Company executives were outspoken about how their attempted takeover of AstraZeneca, which was confirmed early Monday, would help Pfizer slash its tax bill, saving $1 billion or more each year by one estimate.